Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy
Thomas G Cotter,1 Donald M Jensen21Center for Liver Diseases, The University of Chicago Medicine, Chicago, IL, USA; 2Section of Hepatology, RUSH University Medical Center, Chicago, IL, USAAbstract: Direct-acting antiviral (DAA) therapy has changed the landscape of hepatitis C virus (HCV) management...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-07-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/glecaprevirpibrentasvir-for-the-treatment-of-chronic-hepatitis-c-desig-peer-reviewed-article-DDDT |